Search

Your search keyword '"Zuccato E."' showing total 206 results

Search Constraints

Start Over You searched for: Author "Zuccato E." Remove constraint Author: "Zuccato E."
206 results on '"Zuccato E."'

Search Results

101. Wastewater-Based Epidemiology To Monitor Synthetic Cathinones Use in Different European Countries.

102. Source discrimination of drug residues in wastewater: The case of salbutamol.

103. Screening new psychoactive substances in urban wastewater using high resolution mass spectrometry.

104. Population surveys compared with wastewater analysis for monitoring illicit drug consumption in Italy in 2010-2014.

105. Illicit drug consumption estimated by wastewater analysis in different districts of Milan: A case study.

106. High resolution mass spectrometry to investigate omeprazole and venlafaxine metabolites in wastewater.

107. Alcohol and cocaine co-consumption in two European cities assessed by wastewater analysis.

108. Realistic mixture of illicit drugs impaired the oxidative status of the zebra mussel (Dreissena polymorpha).

109. Wastewater analysis to monitor spatial and temporal patterns of use of two synthetic recreational drugs, ketamine and mephedrone, in Italy.

110. Wastewater analysis to monitor use of caffeine and nicotine and evaluation of their metabolites as biomarkers for population size assessment.

111. Prioritization and analysis of pharmaceuticals for human use contaminating the aquatic ecosystem in Italy.

112. Sources and fate of perfluorinated compounds in the aqueous environment and in drinking water of a highly urbanized and industrialized area in Italy.

113. A novel approach for monitoring tobacco use in local communities by wastewater analysis.

114. Sewage epidemiology and illicit drug research: the development of ethical research guidelines.

115. Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers.

116. Changes in illicit drug consumption patterns in 2009 detected by wastewater analysis.

117. Identification of cocaine and its metabolites in urban wastewater and comparison with the human excretion profile in urine.

118. Illicit drug consumption estimations derived from wastewater analysis: a critical review.

119. PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants' daily intake: a review.

120. The effect of waste combustion on the occurrence of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) in breast milk in Italy.

121. Source, occurrence and fate of antibiotics in the Italian aquatic environment.

122. Polychlorobiphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) in fruit and vegetables from an industrial area in northern Italy.

124. Illicit drugs in the environment.

125. Novel homologs of the multiple resistance regulator marA in antibiotic-contaminated environments.

126. Estimating community drug abuse by wastewater analysis.

127. Mass spectrometric analysis of illicit drugs in wastewater and surface water.

128. Effects and interactions in an environmentally relevant mixture of pharmaceuticals.

129. Illicit drugs, a novel group of environmental contaminants.

130. Gene expression profiles in zebrafish (Danio rerio) liver cells exposed to a mixture of pharmaceuticals at environmentally relevant concentrations.

131. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation.

132. Direct analysis of isopropylthioxanthone (ITX) in milk by high-performance liquid chromatography/tandem mass spectrometry.

133. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry.

134. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells.

135. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control.

136. Removal of pharmaceuticals in sewage treatment plants in Italy.

137. A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters.

138. Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse.

139. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.

140. Antibiotics in the environment: occurrence in Italian STPs, fate, and preliminary assessment on algal toxicity of amoxicillin.

141. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.

142. Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy.

143. Promoter architecture modulates CFTR exon 9 skipping.

144. Risks and benefits of PVC in medical applications.

145. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

146. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.

148. Presence of therapeutic drugs in the environment.

149. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.

150. Utility of Hydrogen and Methane Breath Tests in Combination with X-Ray Examination after a Barium Meal in the Diagnosis of Small Bowel Bacterial Overgrowth after Jejuno-Ileal Bypass for Morbid Obesity.

Catalog

Books, media, physical & digital resources